Dronedarone for AF rejected in draft NICE guidance Dronedarone is not cost effective for AF treatment and cannot be recommended for use in the NHS, draft NICE guidance has concluded. by Tom Moberly Sign in to continue Sign In Email address Password Stay signed in Trouble signing in? Reset password: Click here Need help? Email us Register FREE Limited free articles a month Free email bulletins Register Now Register Now Take a 30-day trial Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days Sign Up Sign Up
